Rezultati - Boss, Anders
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in... od Roborel de Climens, Aude, Pain, Emilie, Boss, Anders, Shaunik, Alka
Izdano 2020Text -
7
Modeling the Effect of Subcutaneous Lixisenatide on Glucoregulatory Endocrine Secretions and Gastric Emptying in Type 2 Diabetes to Simulate the Effect of iGlarLixi Administration... od Gautier, Thibault, Silwal, Rupesh, Saremi, Aramesh, Boss, Anders, Breton, Marc D.
Izdano 2021Text -
8
-
9
Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐like peptide‐1 receptor agonist... od Rosenstock, Julio, Ampudia‐Blasco, Francisco Javier, Lubwama, Robert, Peng, Xuejun Victor, Boss, Anders, Shi, Lizheng, Fonseca, Vivian
Izdano 2020Text -
10
Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator od Visentin, Roberto, Giegerich, Clemens, Jäger, Robert, Dahmen, Raphael, Boss, Anders, Grant, Marshall, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas
Izdano 2016Text -
11
Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study od Peng, Xuejun Victor, McCrimmon, Rory J., Shepherd, Leah, Boss, Anders, Lubwama, Robert, Dex, Terry, Skolnik, Neil, Ji, Linong, Avogaro, Angelo, Blonde, Lawrence
Izdano 2020Text -
12
Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents od Rosenstock, Julio, Bergenstal, Richard, DeFronzo, Ralph A., Hirsch, Irl B., Klonoff, David, Boss, Anders H., Kramer, David, Petrucci, Richard, Yu, Wen, Levy, Brian
Izdano 2008Text -
13
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA od Blonde, Lawrence, Meneghini, Luigi, Peng, Xuejun Victor, Boss, Anders, Rhee, Kyu, Shaunik, Alka, Kumar, Supriya, Balodi, Sidhartha, Brulle-Wohlhueter, Claire, McCrimmon, Rory J.
Izdano 2018Text -
14
Randomized Forced Titration to Different Doses of Technosphere® Insulin Demonstrates Reduction in Postprandial Glucose Excursions and Hemoglobin A1c in Patients with Type 2 Diabete... od Tack, Cees J., Christov, Vladimir, de Galan, Bastiaan E., Derwahl, Karl-Michael, Klausmann, Gerhard, Pelikánová, Terezie, Perušičová, Jindra, Boss, Anders H., Amin, Nikhil, Kramer, David, Petrucci, Richard, Yu, Wen
Izdano 2008Text